For 60 years, Parkinson’s was defined as a disease of dopamine deficiency.

If that were true, then why doesn’t increasing dopamine control the disease?

Because dopamine deficiency doesn’t cause Parkinson’s, even though its levels are low in brain tissue.

Right Brain Bio discovered that the cause of neurodegeneration and disability in Parkinson's is excess dopamine inside brain cells.

Next, we identified a drug proven in eight lab models to reverse the pathology, one that lowers dopamine synthesis.

When the data and the plan were shared with the FDA, it confirmed the drug is ready for Phase 2 clinical trials.